For the Inventor, By the Inventor

Enter assignee name

New Haven, CT, United States of America

Karos Pharmaceuticals, Inc.

USPTO Granted Patents = 3

% Expired Patents = 66.7

CIPO Patents = 4

EPO Patents = 1

Forward Citations = 27

Loading Chart...

Loading Chart...

5 inventors (with patents filed for the assignee):

Stéphane De Lombaert (3 out of 13 patents)

Daniel R Goldberg (3 out of 53 patents)

Kenneth Albert Brameld (2 out of 27 patents)

4. Eric Brian Sjogren (2 out of 64 patents)

5. Andrew Scribner (1 out of 12 patents)

6. Stephane De Lombaert (15 patents)

3 patents: Sort by Forward Citations

1. 9611201 - Processes for preparing (R)-1-(5-chloro-[1,1'-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone (2017-04-04),

2. 9512122 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2016-12-06),

3. 9199994 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2015-12-01),

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

3 Patents

#49 in New Haven, CT

#1,395 in Connecticut

#73,766 in US

New Haven, CT, United States of America

Karos Pharmaceuticals, Inc.

Forward Citations = 27

5 inventors:

Stéphane De Lombaert (3 out of 13 patents)

Daniel R Goldberg (3 out of 53 patents)

Kenneth Albert Brameld (2 out of 27 patents)

4. Eric Brian Sjogren (2 out of 64 patents)

5. Andrew Scribner (1 out of 12 patents)

Please report any incorrect information to [email protected]

Loading…